<DOC>
	<DOCNO>NCT00130390</DOCNO>
	<brief_summary>The primary objective study evaluate efficacy safety nitazoxanide compare placebo reduce sign symptom mild moderate active Crohn 's disease adult .</brief_summary>
	<brief_title>Study Nitazoxanide Tablets Treatment Mild Moderate Active Crohn 's Disease</brief_title>
	<detailed_description>There significant need safe effective treatment Crohn 's disease . It recognize bacteria gut lumen may role etiology and/or symptom disease . Antimicrobials often use treat Crohn 's disease although effectiveness well establish . Pro-inflammatory cytokine also believe play important role disease . Nitazoxanide , thiazolide anti-infective , active vitro broad spectrum anaerobic bacteria , inhibits secretion pro-inflammatory cytokine include IL-2 , -4 , -5 , -6 , -8 , -10 TNF alpha . The drug also highly concentrated gastrointestinal tract . With characteristic , nitazoxanide offer unique approach treatment Crohn 's disease .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Nitazoxanide</mesh_term>
	<criteria>Age ≥18 year . Diagnosis Crohn 's disease colonic perianal involvement confirm endoscopic , histologic and/or radiologic data . CDAI score ≥200 ≤400 . Subjects know stool positive Clostridium difficile toxin A B , bacterial enteric pathogen , rotavirus , Cryptosporidium specie ( spp . ) , and/or ova/parasites . Evidence bowel obstruction . Females pregnant , breastfeed use birth control sexually active . Serious systemic disorder incompatible study . History hypersensitivity nitazoxanide inactive ingredient formulation . Uncontrolled gastrointestinal bleeding . Evidence intestinal abscess , nonperianal fistula stricture . Patients receive antibiotic past 7 day . Patients receive &gt; 20 mg prednisone , equivalent . Patients receive AnucortHC rectal steroid . Patients receive immunosuppressive therapy stabilize . Patients receive TNFalpha inhibitor treatment infliximab biological agent within three month prior start treatment . Patients Crohn 's disease confine esophagus , stomach small bowel .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Crohn 's Disease</keyword>
</DOC>